Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.8%

1 terminated out of 26 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

89% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (9)
P 1 (1)
P 2 (1)
P 4 (1)

Trial Status

Recruiting8
Completed8
Not Yet Recruiting3
Unknown3
Active Not Recruiting3
Terminated1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT06983366Recruiting

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

NCT07531446Active Not Recruiting

Construction of a Clinico-Imaging Collaborative Diagnostic Model for Dermatomyositis Combined With Interstitial Lung Disease Based on PET/CT Imaging Features and Clinical Parameters

NCT06012500Phase 1Active Not RecruitingPrimary

Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease

NCT05092035Not ApplicableCompleted

Recognition of Early Pulmonary Structural Changes by Using Real-time High Fidelity Expiratory CO2 Analysis

NCT07344987Not ApplicableNot Yet RecruitingPrimary

Effect of Indoor Air Quality Improvement on Health in Patients With Interstitial Lung Disease

NCT05086432Not ApplicableRecruitingPrimary

Sputum Cytometry Guided Management for the Elimination of Chronic Cough in Patients With ILD

NCT07102589Recruiting

SWEEP: Shuttle Walking Test for Exercise Evaluation in Pulmonary Resection

NCT07060079Recruiting

The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease

NCT07035561Phase 2Completed

Rituximab Therapy in Patients With Treatment Refractory Hypersenstivity Pneumonitis

NCT05469555Completed

Azithromycin and Oesophageal Function in Respiratory Disease

NCT06290635CompletedPrimary

Edmonton Dyspnea Inventory- Validation Study

NCT04767074Not ApplicableRecruiting

A Non-pharmacological Cough Control Therapy

NCT04564183Active Not Recruiting

Advancing Prevention of Pulmonary Fibrosis

NCT06882265Not ApplicableRecruitingPrimary

Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy

NCT06617078Not ApplicableNot Yet RecruitingPrimary

Benefit of High-flow Nasal Cannula on Persistent Dyspnea in Ild

NCT06503757Not Yet RecruitingPrimary

ILD In Obese Patients With OSA

NCT04311567Phase 4Terminated

Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease

NCT06280443Recruiting

Sarcopenia in Chronic Lung Diseases

NCT06167811Not ApplicableUnknownPrimary

Acute Effect of Whole-body Electrical Stimulation in ILD Patients

NCT06198608UnknownPrimary

Misdiagnosis Between Interstitial Lung Disease and Cardiac Patients

Scroll to load more

Research Network

Activity Timeline